Cargando…
Transcriptional Regulation of Fibroblast Growth Factor 21 Expression
Fibroblast growth factor 21 (FGF21) is an attractive target for treating metabolic disease due to its wide-ranging beneficial effects on glucose and lipid metabolism. Circulating FGF21 levels are increased in insulin-resistant states; however, endogenous FGF21 fails to improve glucose and lipid meta...
Autores principales: | Bae, Kwi-Hyun, Kim, Jung-Guk, Park, Keun-Gyu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Endocrine Society
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4091486/ https://www.ncbi.nlm.nih.gov/pubmed/25031882 http://dx.doi.org/10.3803/EnM.2014.29.2.105 |
Ejemplares similares
-
Exercise-Induced Fibroblast Growth Factor-21: A Systematic Review and Meta-Analysis
por: Kim, Hyunjoong, et al.
Publicado: (2023) -
Identification of Sp1 as a Transcription Activator to Regulate Fibroblast Growth Factor 21 Gene Expression
por: Chen, Shuqin, et al.
Publicado: (2017) -
Clinical Characteristics for 348 Patients with Adrenal Incidentaloma
por: Kim, Jongho, et al.
Publicado: (2013) -
Fibroblast Growth Factor 21: A Novel Metabolic Regulator
por: Seo, Ji A, et al.
Publicado: (2012) -
Fibroblast growth factor 21 and bone homeostasis
por: Tang, Yan, et al.
Publicado: (2023)